Pinotbio

Provider of therapeutics solution for cancer, glaucoma and other diseases

placeSuwon-si, Gyeonggi-do, South Korea calendar_todayFounded 2017 groups9 employees language pinotbio.com

Registered entities

Innovation

35 patent families (3 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace accelerating. Cited 334 times.

YearFilings
20214
20228
202313
202416
202516
20263

Investor mix

14 investors on record; lead investors include LOTTE BIOLOGICS.

Investor typeCountShare
Venture capital643%
Private equity643%
Other / undisclosed214%
Coming soon